Showing results (1201-1210 of 1,326) with videos related to

Sort By:
Pageof 133
Psychiatry Research|July 2, 2024
Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysisGia Han Le, Angela T H Kwan, Ziji Guo, et al.
Bipolar Disorders|May 2, 2020
Call to action regarding the vascular-bipolar link: A report from the Vascular Task Force of the International Society for Bipolar DisordersBenjamin I Goldstein, Bernhard T Baune, David J Bond, et al.
Journal of Affective Disorders|December 9, 2020
Effects of infliximab on brain neurochemistry of adults with bipolar depressionRodrigo B Mansur, Mehala Subramaniapillai, Yena Lee, et al.
Advances in Therapy|December 20, 2023
Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary AnalysisGia Han Le, Angela T H Kwan, Sabrina Wong, et al.
The American Journal of Psychiatry|August 3, 2004
Improving access to geriatric mental health services: a randomized trial comparing treatment engagement with integrated versus enhanced referral care for depression, anxiety, and at-risk alcohol useStephen J Bartels, Eugenie H Coakley, Cynthia Zubritsky, et al.
CNS Spectrums|November 25, 2024
A systematic review on the efficacy of GLP-1 receptor agonists in mitigating psychotropic drug-related weight gainTrisha Menon, Serene Lee, Xuan Yi Gong, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 8, 2020
Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatmentAshley N Siegel, Nelson Rodrigues, Flora Nasri, et al.
World Neurosurgery|December 24, 2023
Anxiety and Depression in Pediatric-Onset Traumatic Spinal Cord Injury: A Systematic ReviewMohammad Mofatteh, Mohammad Sadegh Mashayekhi, Saman Arfaie, et al.
Annals of General Psychiatry|February 29, 2024
Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetineAngela T H Kwan, Gia Han Le, Ziji Guo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 5, 2017
Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disordersRodrigo B Mansur, Andre Zugman, Juhie Ahmed, et al.
Pageof 133